South Dakota Cannabis License

Estimated reading time: 4 minutes

What’s on the Ballot?
Key Features of Amendment A
What Does Measure 26 Offer?
A Unique Opportunity for Cannabis Entrepreneurs
The Economic Impact
Take the Next Step
Additional Resources
Consulting Services For Cannabis, Hemp, Psilocybin, and Natural Medicine
Testimonials and Public Relations
Latest Articles
Explore Our Articles
Free Ebook – Start Your Own Legal Cannabis Business

The upcoming vote on November 3, 2020, may open the door for a South Dakota Cannabis License. This historic event marks the first time a state will simultaneously vote on both medical and adult-use cannabis legalization. By doing so, South Dakota is positioning itself as a progressive leader in marijuana reform.

What’s on the Ballot?

South Dakota voters will decide on two measures: Amendment A and Measure 26. Each requires a majority vote to pass.

Amendment A: This amendment to the South Dakota Constitution would legalize, regulate, and tax marijuana for adult use. It allows adults aged 21 and older to possess up to one ounce of marijuana and, under specific conditions, grow marijuana plants at home. Additionally, it grants the State Department of Revenue authority to issue licenses for cannabis businesses, including cultivators, manufacturers, and retailers. Local governments may regulate or ban such establishments within their jurisdictions.
Measure 26: This initiative establishes a medical marijuana program for qualifying patients, including minors. The measure takes a less restrictive approach, defining qualifying conditions broadly to ensure patients in need have access to medical cannabis. Patients could possess up to three ounces of marijuana or the amount prescribed by a physician. Non-resident medical patients with valid registration cards could also purchase cannabis in South Dakota.

Key Features of Amendment A

If passed, Amendment A would bring several changes to South Dakota:

Legalization of possession, use, transport, and distribution of marijuana for adults 21 and older.
Home cultivation of marijuana plants under certain conditions.
State-regulated licensing for cannabis businesses.
Revenue generation through application fees, licensing fees, and a 15% excise tax.

Revenue collected would fund the program’s implementation. Any surplus would be split between public schools and the state general fund. By 2023, projected tax revenues could reach nearly $20 million annually.

What Does Measure 26 Offer?

Measure 26 focuses on medical cannabis accessibility. Key provisions include:

Broad definitions of debilitating medical conditions to cover a wide range of patient needs.
Allowing home cultivation of cannabis plants for registered patients.
Enabling non-resident medical marijuana patients to access South Dakota dispensaries.

This inclusive approach ensures that all patients who could benefit from medical cannabis have safe and legal access.

A Unique Opportunity for Cannabis Entrepreneurs

Most states have introduced medical cannabis programs before expanding to adult-use legalization. South Dakota’s simultaneous approach could create immediate opportunities for cannabis business entrepreneurs. If Amendment A passes, the state will issue licenses to qualified applicants, paving the way for a thriving cannabis industry. This new sector will bring essential jobs and exciting career opportunities to the state.

The Economic Impact

The financial benefits of legalization are significant. Initial projections suggest the state could generate over $355,000 in net revenue in 2021. By 2023, this figure is expected to approach $20 million. These funds will support schools and the state’s general fund, providing a much-needed economic boost.

Take the Next Step

The passage of Amendment A or Measure 26 will lay the foundation for a booming industry in South Dakota. If you’re interested in applying for a South Dakota Cannabis License, contact us today to learn more.

Additional Resources

Consulting Services For Cannabis, Hemp, Psilocybin, and Natural Medicine

Testimonials and Public Relations

Latest Articles

The Fiduciary Mandate: Why an Owner’s Rep is the Key to 2026 Cannabis Retail Success
In the cannabis retail landscape of 2026, the era of “opening at any cost” has ended. As capital markets remain disciplined and consumer margins tighten, the difference between a profitable dispensary and a “zombie project” is determined during the buildout phase.
Open a Cannabis Consumption Lounge in New Jersey: 2026 Guide to Compliance and Success
As of April 2026, the New Jersey cannabis market has matured into a sophisticated $4 billion powerhouse. The initial “novelty” phase has passed, and the industry is now defined by “Hospitality 2.0,” where consumption areas are becoming social anchors for local tourism in hubs like Atlantic City, Newark, and Jersey City.
New York Cannabis Lounge License: Expert Guide to Compliance and Success
The New York cannabis industry has transitioned from a volatile implementation phase into a “Pharma-Grade” era of structural maturity. As of April 2026, the state has reached a monumental economic milestone, with total reported retail sales officially surpassing $3,000,000,000. For entrepreneurs, the current frontier is the “social hospitality” sector, which is defined by high-stakes technical compliance and rigorous municipal negotiation.
The 2026 New York Execution Gap: Scaling Your Cannabis Business
The trajectory of the New York cannabis industry has transitioned from a period of experimental regulation to one of massive commercial consolidation and operational intensity. As of April 15, 2026, the state has officially matured into its role as the second-largest cannabis market in the United States, trailing only California in total economic activity and consumer demand. The primary indicator of this success is the milestone reached in early 2026, where total reported retail sales since the inception of the legal program surpassed $2.97 billion.
Regulatory Maturity and Market Dynamics: A Comprehensive Analysis of the New Jersey Cannabis Industry
The legal landscape of cannabis in New Jersey has transitioned from a period of rapid legislative enactment into an era of complex regulatory maturity and secondary market correction. Since the foundational passage of the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMMA) in early 2021, the state has systematically dismantled the architecture of prohibition while constructing a highly regulated, billion-dollar industry.
Nebraska Medical Cannabis Market Strategic Report: Navigating the Regulatory Landscape and Licensing Framework 2026
The Nebraska medical cannabis industry has undergone a radical transformation from its nascent beginnings in the 2024 general election to the highly structured, albeit restrictive, regulatory environment of April 2026. This period has been characterized by intense legislative maneuvering, high-stakes licensing competitions, and a fundamental shift in the state’s administrative approach to controlled substances.

South Dakota Cannabis License: Key Insights on Medical and Recreational Legalization Vote 2020

Table of contents